MRPL48 is a novel prognostic and predictive biomarker of hepatocellular carcinoma

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
1 Online-Ressource.
Sprache
Englisch

Erschienen in
MRPL48 is a novel prognostic and predictive biomarker of hepatocellular carcinoma ; volume:28 ; number:1 ; day:14 ; month:12 ; year:2023 ; pages:1-17 ; date:12.2023
European journal of medical research ; 28, Heft 1 (14.12.2023), 1-17, 12.2023

Urheber
Lin, Yu-Xiang
Pan, Jun-Yong
Feng, Wen-Du
Huang, Tian-Cong
Li, Cheng-Zong
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s40001-023-01571-z
URN
urn:nbn:de:101:1-2024022913573989413885
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:50 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Lin, Yu-Xiang
  • Pan, Jun-Yong
  • Feng, Wen-Du
  • Huang, Tian-Cong
  • Li, Cheng-Zong
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Potential prognostic biomarker SERPINA12: implications for hepatocellular carcinoma

Potential prognostic biomarker SERPINA12: implications for hepatocellular carcinoma

APOB is a potential prognostic biomarker in hepatocellular carcinoma

APOB is a potential prognostic biomarker in hepatocellular carcinoma

CYB561 a potential prognostic biomarker for liver hepatocellular carcinoma

CYB561 a potential prognostic biomarker for liver hepatocellular carcinoma

Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma

Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma

SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma

SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma

Biomarker in Hepatocellular Carcinoma

Biomarker in Hepatocellular Carcinoma

Identification of CELSR2 as a novel prognostic biomarker for hepatocellular carcinoma

Identification of CELSR2 as a novel prognostic biomarker for hepatocellular carcinoma

Plasma CD24 level as a promising prognostic biomarker of hepatocellular carcinoma

Plasma CD24 level as a promising prognostic biomarker of hepatocellular carcinoma

Comprehensive analysis identifies CLEC1B as a potential prognostic biomarker in hepatocellular carcinoma

Comprehensive analysis identifies CLEC1B as a potential prognostic biomarker in hepatocellular carcinoma

PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma

PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma

Comprehensive analysis of POLH-AS1 as a prognostic biomarker in hepatocellular carcinoma

Comprehensive analysis of POLH-AS1 as a prognostic biomarker in hepatocellular carcinoma

Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma

Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma

Verbundene Objekte